Cargando…
Advancing clinical oncology through genome biology and technology
The use of genomic technologies for the molecular characterization of tumors has propelled our understanding of cancer biology and is transforming the way patients with cancer are diagnosed and treated.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281954/ https://www.ncbi.nlm.nih.gov/pubmed/25198155 http://dx.doi.org/10.1186/s13059-014-0427-x |
| _version_ | 1782351054045708288 |
|---|---|
| author | Varghese, Anna M Berger, Michael F |
| author_facet | Varghese, Anna M Berger, Michael F |
| author_sort | Varghese, Anna M |
| collection | PubMed |
| description | The use of genomic technologies for the molecular characterization of tumors has propelled our understanding of cancer biology and is transforming the way patients with cancer are diagnosed and treated. |
| format | Online Article Text |
| id | pubmed-4281954 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42819542015-01-03 Advancing clinical oncology through genome biology and technology Varghese, Anna M Berger, Michael F Genome Biol Opinion The use of genomic technologies for the molecular characterization of tumors has propelled our understanding of cancer biology and is transforming the way patients with cancer are diagnosed and treated. BioMed Central 2014-08-07 2014 /pmc/articles/PMC4281954/ /pubmed/25198155 http://dx.doi.org/10.1186/s13059-014-0427-x Text en © Berger and Varghese; licensee BioMed Central 2014 The licensee has exclusive rights to distribute this article, in any medium, for 12 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Opinion Varghese, Anna M Berger, Michael F Advancing clinical oncology through genome biology and technology |
| title | Advancing clinical oncology through genome biology and technology |
| title_full | Advancing clinical oncology through genome biology and technology |
| title_fullStr | Advancing clinical oncology through genome biology and technology |
| title_full_unstemmed | Advancing clinical oncology through genome biology and technology |
| title_short | Advancing clinical oncology through genome biology and technology |
| title_sort | advancing clinical oncology through genome biology and technology |
| topic | Opinion |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281954/ https://www.ncbi.nlm.nih.gov/pubmed/25198155 http://dx.doi.org/10.1186/s13059-014-0427-x |
| work_keys_str_mv | AT vargheseannam advancingclinicaloncologythroughgenomebiologyandtechnology AT bergermichaelf advancingclinicaloncologythroughgenomebiologyandtechnology |